nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.371	1	CpDpCtD
Sulindac—CYP1A1—chronic obstructive pulmonary disease	0.15	0.397	CbGaD
Sulindac—CYP1A2—chronic obstructive pulmonary disease	0.145	0.382	CbGaD
Sulindac—ALB—chronic obstructive pulmonary disease	0.0835	0.221	CbGaD
Sulindac—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0401	0.522	CbGbCtD
Sulindac—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0201	0.262	CbGbCtD
Sulindac—ALB—Prednisone—chronic obstructive pulmonary disease	0.0166	0.216	CbGbCtD
Sulindac—AKR1B1—respiratory system—chronic obstructive pulmonary disease	0.00233	0.0824	CbGeAlD
Sulindac—AKR1B1—connective tissue—chronic obstructive pulmonary disease	0.00205	0.0725	CbGeAlD
Sulindac—AKR1B1—bronchus—chronic obstructive pulmonary disease	0.00192	0.0678	CbGeAlD
Sulindac—AKR1B1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00188	0.0663	CbGeAlD
Sulindac—PTGS2—leg—chronic obstructive pulmonary disease	0.00177	0.0625	CbGeAlD
Sulindac—AKR1B1—trachea—chronic obstructive pulmonary disease	0.00172	0.0609	CbGeAlD
Sulindac—MAPK3—respiratory system—chronic obstructive pulmonary disease	0.00169	0.0597	CbGeAlD
Sulindac—MAPK3—connective tissue—chronic obstructive pulmonary disease	0.00149	0.0526	CbGeAlD
Sulindac—MAPK3—bronchus—chronic obstructive pulmonary disease	0.00139	0.0491	CbGeAlD
Sulindac—MAPK3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00136	0.0481	CbGeAlD
Sulindac—MAPK3—trachea—chronic obstructive pulmonary disease	0.00125	0.0441	CbGeAlD
Sulindac—AKR1B1—lung—chronic obstructive pulmonary disease	0.00124	0.0437	CbGeAlD
Sulindac—PPARD—lung—chronic obstructive pulmonary disease	0.000974	0.0344	CbGeAlD
Sulindac—MAPK3—lung—chronic obstructive pulmonary disease	0.000898	0.0317	CbGeAlD
Sulindac—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.00053	0.0187	CbGeAlD
Sulindac—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000523	0.0185	CbGeAlD
Sulindac—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.00046	0.0162	CbGeAlD
Sulindac—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000439	0.0155	CbGeAlD
Sulindac—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000431	0.0152	CbGeAlD
Sulindac—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000405	0.0143	CbGeAlD
Sulindac—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000387	0.0137	CbGeAlD
Sulindac—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000387	0.0137	CbGeAlD
Sulindac—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00037	0.0131	CbGeAlD
Sulindac—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000362	0.0128	CbGeAlD
Sulindac—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000354	0.0125	CbGeAlD
Sulindac—PTGS1—trachea—chronic obstructive pulmonary disease	0.00034	0.012	CbGeAlD
Sulindac—PTGS2—trachea—chronic obstructive pulmonary disease	0.000325	0.0115	CbGeAlD
Sulindac—CYP1A2—lung—chronic obstructive pulmonary disease	0.000282	0.00994	CbGeAlD
Sulindac—CYP1A1—lung—chronic obstructive pulmonary disease	0.000278	0.00981	CbGeAlD
Sulindac—PTGS1—lung—chronic obstructive pulmonary disease	0.000244	0.00862	CbGeAlD
Sulindac—PTGS2—lung—chronic obstructive pulmonary disease	0.000233	0.00824	CbGeAlD
Sulindac—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00019	0.00247	CcSEcCtD
Sulindac—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00246	CcSEcCtD
Sulindac—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000188	0.00245	CcSEcCtD
Sulindac—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.00245	CcSEcCtD
Sulindac—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000188	0.00245	CcSEcCtD
Sulindac—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000187	0.00243	CcSEcCtD
Sulindac—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000186	0.00242	CcSEcCtD
Sulindac—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.00242	CcSEcCtD
Sulindac—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000184	0.0024	CcSEcCtD
Sulindac—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000183	0.00239	CcSEcCtD
Sulindac—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00237	CcSEcCtD
Sulindac—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00237	CcSEcCtD
Sulindac—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000181	0.00235	CcSEcCtD
Sulindac—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00235	CcSEcCtD
Sulindac—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000178	0.00232	CcSEcCtD
Sulindac—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000178	0.00232	CcSEcCtD
Sulindac—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.00231	CcSEcCtD
Sulindac—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000178	0.00231	CcSEcCtD
Sulindac—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00231	CcSEcCtD
Sulindac—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000175	0.00228	CcSEcCtD
Sulindac—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00228	CcSEcCtD
Sulindac—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00228	CcSEcCtD
Sulindac—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00228	CcSEcCtD
Sulindac—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00228	CcSEcCtD
Sulindac—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00228	CcSEcCtD
Sulindac—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00228	CcSEcCtD
Sulindac—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00228	CcSEcCtD
Sulindac—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00228	CcSEcCtD
Sulindac—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00227	CcSEcCtD
Sulindac—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000175	0.00227	CcSEcCtD
Sulindac—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00227	CcSEcCtD
Sulindac—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00226	CcSEcCtD
Sulindac—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00226	CcSEcCtD
Sulindac—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00224	CcSEcCtD
Sulindac—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00224	CcSEcCtD
Sulindac—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00224	CcSEcCtD
Sulindac—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00223	CcSEcCtD
Sulindac—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00017	0.00222	CcSEcCtD
Sulindac—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00219	CcSEcCtD
Sulindac—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00219	CcSEcCtD
Sulindac—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00219	CcSEcCtD
Sulindac—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00219	CcSEcCtD
Sulindac—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00219	CcSEcCtD
Sulindac—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00218	CcSEcCtD
Sulindac—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00216	CcSEcCtD
Sulindac—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00216	CcSEcCtD
Sulindac—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00216	CcSEcCtD
Sulindac—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000165	0.00215	CcSEcCtD
Sulindac—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00214	CcSEcCtD
Sulindac—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00214	CcSEcCtD
Sulindac—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00214	CcSEcCtD
Sulindac—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00214	CcSEcCtD
Sulindac—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00213	CcSEcCtD
Sulindac—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00213	CcSEcCtD
Sulindac—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.00212	CcSEcCtD
Sulindac—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000161	0.0021	CcSEcCtD
Sulindac—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00207	CcSEcCtD
Sulindac—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00207	CcSEcCtD
Sulindac—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000157	0.00204	CcSEcCtD
Sulindac—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.00204	CcSEcCtD
Sulindac—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.00204	CcSEcCtD
Sulindac—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.00203	CcSEcCtD
Sulindac—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00203	CcSEcCtD
Sulindac—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00203	CcSEcCtD
Sulindac—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00202	CcSEcCtD
Sulindac—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000153	0.002	CcSEcCtD
Sulindac—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.002	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00199	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00199	CcSEcCtD
Sulindac—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00198	CcSEcCtD
Sulindac—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00198	CcSEcCtD
Sulindac—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00197	CcSEcCtD
Sulindac—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000151	0.00197	CcSEcCtD
Sulindac—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00196	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00195	CcSEcCtD
Sulindac—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00015	0.00195	CcSEcCtD
Sulindac—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.00195	CcSEcCtD
Sulindac—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00195	CcSEcCtD
Sulindac—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00195	CcSEcCtD
Sulindac—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000149	0.00194	CcSEcCtD
Sulindac—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00193	CcSEcCtD
Sulindac—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00193	CcSEcCtD
Sulindac—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00193	CcSEcCtD
Sulindac—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00193	CcSEcCtD
Sulindac—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00192	CcSEcCtD
Sulindac—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.00192	CcSEcCtD
Sulindac—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00191	CcSEcCtD
Sulindac—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000146	0.0019	CcSEcCtD
Sulindac—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00189	CcSEcCtD
Sulindac—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.00189	CcSEcCtD
Sulindac—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000145	0.00189	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00188	CcSEcCtD
Sulindac—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000144	0.00187	CcSEcCtD
Sulindac—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.00187	CcSEcCtD
Sulindac—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00187	CcSEcCtD
Sulindac—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.00186	CcSEcCtD
Sulindac—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000142	0.00185	CcSEcCtD
Sulindac—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00184	CcSEcCtD
Sulindac—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00184	CcSEcCtD
Sulindac—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00014	0.00183	CcSEcCtD
Sulindac—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.00182	CcSEcCtD
Sulindac—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00182	CcSEcCtD
Sulindac—Purpura—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00182	CcSEcCtD
Sulindac—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000139	0.00181	CcSEcCtD
Sulindac—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000139	0.00181	CcSEcCtD
Sulindac—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.00181	CcSEcCtD
Sulindac—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000138	0.0018	CcSEcCtD
Sulindac—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.0018	CcSEcCtD
Sulindac—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000138	0.0018	CcSEcCtD
Sulindac—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.0018	CcSEcCtD
Sulindac—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000138	0.00179	CcSEcCtD
Sulindac—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.00179	CcSEcCtD
Sulindac—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000137	0.00179	CcSEcCtD
Sulindac—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00178	CcSEcCtD
Sulindac—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.00177	CcSEcCtD
Sulindac—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000135	0.00175	CcSEcCtD
Sulindac—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00175	CcSEcCtD
Sulindac—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00174	CcSEcCtD
Sulindac—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00174	CcSEcCtD
Sulindac—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.00173	CcSEcCtD
Sulindac—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000133	0.00173	CcSEcCtD
Sulindac—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000132	0.00172	CcSEcCtD
Sulindac—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000131	0.00171	CcSEcCtD
Sulindac—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000131	0.00171	CcSEcCtD
Sulindac—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000131	0.00171	CcSEcCtD
Sulindac—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000131	0.0017	CcSEcCtD
Sulindac—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.0017	CcSEcCtD
Sulindac—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00013	0.0017	CcSEcCtD
Sulindac—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00013	0.00169	CcSEcCtD
Sulindac—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.00169	CcSEcCtD
Sulindac—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00164	CcSEcCtD
Sulindac—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00163	CcSEcCtD
Sulindac—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00161	CcSEcCtD
Sulindac—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00161	CcSEcCtD
Sulindac—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000124	0.00161	CcSEcCtD
Sulindac—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00161	CcSEcCtD
Sulindac—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00158	CcSEcCtD
Sulindac—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.00157	CcSEcCtD
Sulindac—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000121	0.00157	CcSEcCtD
Sulindac—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.00155	CcSEcCtD
Sulindac—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000119	0.00155	CcSEcCtD
Sulindac—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00155	CcSEcCtD
Sulindac—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000118	0.00154	CcSEcCtD
Sulindac—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00152	CcSEcCtD
Sulindac—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000116	0.00152	CcSEcCtD
Sulindac—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000115	0.0015	CcSEcCtD
Sulindac—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.0015	CcSEcCtD
Sulindac—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00149	CcSEcCtD
Sulindac—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00148	CcSEcCtD
Sulindac—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.00148	CcSEcCtD
Sulindac—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00148	CcSEcCtD
Sulindac—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00147	CcSEcCtD
Sulindac—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00146	CcSEcCtD
Sulindac—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000111	0.00145	CcSEcCtD
Sulindac—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.00145	CcSEcCtD
Sulindac—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000109	0.00142	CcSEcCtD
Sulindac—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00142	CcSEcCtD
Sulindac—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00141	CcSEcCtD
Sulindac—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000107	0.00139	CcSEcCtD
Sulindac—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.00139	CcSEcCtD
Sulindac—Rash—Formoterol—chronic obstructive pulmonary disease	0.000106	0.00138	CcSEcCtD
Sulindac—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.00138	CcSEcCtD
Sulindac—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.00138	CcSEcCtD
Sulindac—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000106	0.00138	CcSEcCtD
Sulindac—Headache—Formoterol—chronic obstructive pulmonary disease	0.000105	0.00137	CcSEcCtD
Sulindac—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.00137	CcSEcCtD
Sulindac—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00137	CcSEcCtD
Sulindac—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.00137	CcSEcCtD
Sulindac—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00137	CcSEcCtD
Sulindac—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000105	0.00136	CcSEcCtD
Sulindac—Rash—Montelukast—chronic obstructive pulmonary disease	0.000104	0.00135	CcSEcCtD
Sulindac—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000104	0.00135	CcSEcCtD
Sulindac—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00135	CcSEcCtD
Sulindac—Depression—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00135	CcSEcCtD
Sulindac—Headache—Montelukast—chronic obstructive pulmonary disease	0.000103	0.00134	CcSEcCtD
Sulindac—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.00133	CcSEcCtD
Sulindac—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00132	CcSEcCtD
Sulindac—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.00131	CcSEcCtD
Sulindac—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.00131	CcSEcCtD
Sulindac—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.0013	CcSEcCtD
Sulindac—Rash—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.0013	CcSEcCtD
Sulindac—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.0013	CcSEcCtD
Sulindac—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.0013	CcSEcCtD
Sulindac—Nausea—Formoterol—chronic obstructive pulmonary disease	9.98e-05	0.0013	CcSEcCtD
Sulindac—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.98e-05	0.0013	CcSEcCtD
Sulindac—Headache—Salbutamol—chronic obstructive pulmonary disease	9.94e-05	0.00129	CcSEcCtD
Sulindac—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	9.8e-05	0.00128	CcSEcCtD
Sulindac—Nausea—Montelukast—chronic obstructive pulmonary disease	9.78e-05	0.00127	CcSEcCtD
Sulindac—Convulsion—Prednisolone—chronic obstructive pulmonary disease	9.66e-05	0.00126	CcSEcCtD
Sulindac—Hypertension—Prednisolone—chronic obstructive pulmonary disease	9.63e-05	0.00125	CcSEcCtD
Sulindac—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.43e-05	0.00123	CcSEcCtD
Sulindac—Discomfort—Prednisolone—chronic obstructive pulmonary disease	9.38e-05	0.00122	CcSEcCtD
Sulindac—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	9.1e-05	0.00119	CcSEcCtD
Sulindac—Oedema—Prednisolone—chronic obstructive pulmonary disease	9.1e-05	0.00119	CcSEcCtD
Sulindac—Shock—Prednisolone—chronic obstructive pulmonary disease	8.95e-05	0.00117	CcSEcCtD
Sulindac—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.88e-05	0.00116	CcSEcCtD
Sulindac—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.8e-05	0.00115	CcSEcCtD
Sulindac—Flushing—Prednisone—chronic obstructive pulmonary disease	8.64e-05	0.00112	CcSEcCtD
Sulindac—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.00108	CcSEcCtD
Sulindac—Insomnia—Prednisolone—chronic obstructive pulmonary disease	8.23e-05	0.00107	CcSEcCtD
Sulindac—Alopecia—Prednisone—chronic obstructive pulmonary disease	8.23e-05	0.00107	CcSEcCtD
Sulindac—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	8.17e-05	0.00106	CcSEcCtD
Sulindac—Vision blurred—Prednisone—chronic obstructive pulmonary disease	7.64e-05	0.000994	CcSEcCtD
Sulindac—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	7.52e-05	0.000979	CcSEcCtD
Sulindac—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.5e-05	0.000977	CcSEcCtD
Sulindac—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.49e-05	0.000975	CcSEcCtD
Sulindac—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.4e-05	0.000964	CcSEcCtD
Sulindac—Malaise—Prednisone—chronic obstructive pulmonary disease	7.31e-05	0.000952	CcSEcCtD
Sulindac—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.28e-05	0.000948	CcSEcCtD
Sulindac—Syncope—Prednisone—chronic obstructive pulmonary disease	7.27e-05	0.000946	CcSEcCtD
Sulindac—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.23e-05	0.000941	CcSEcCtD
Sulindac—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.12e-05	0.000927	CcSEcCtD
Sulindac—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.02e-05	0.000914	CcSEcCtD
Sulindac—Hypertension—Prednisone—chronic obstructive pulmonary disease	7e-05	0.000911	CcSEcCtD
Sulindac—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.9e-05	0.000898	CcSEcCtD
Sulindac—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.9e-05	0.000898	CcSEcCtD
Sulindac—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.82e-05	0.000888	CcSEcCtD
Sulindac—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.71e-05	0.000873	CcSEcCtD
Sulindac—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.61e-05	0.000861	CcSEcCtD
Sulindac—Oedema—Prednisone—chronic obstructive pulmonary disease	6.61e-05	0.000861	CcSEcCtD
Sulindac—Shock—Prednisone—chronic obstructive pulmonary disease	6.51e-05	0.000847	CcSEcCtD
Sulindac—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.45e-05	0.00084	CcSEcCtD
Sulindac—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.39e-05	0.000833	CcSEcCtD
Sulindac—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.3e-05	0.000821	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.03e-05	0.000785	CcSEcCtD
Sulindac—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.02e-05	0.000784	CcSEcCtD
Sulindac—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.98e-05	0.000779	CcSEcCtD
Sulindac—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.94e-05	0.000773	CcSEcCtD
Sulindac—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.82e-05	0.000758	CcSEcCtD
Sulindac—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.75e-05	0.000749	CcSEcCtD
Sulindac—Rash—Prednisolone—chronic obstructive pulmonary disease	5.74e-05	0.000747	CcSEcCtD
Sulindac—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.73e-05	0.000747	CcSEcCtD
Sulindac—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.7e-05	0.000742	CcSEcCtD
Sulindac—Headache—Prednisolone—chronic obstructive pulmonary disease	5.7e-05	0.000742	CcSEcCtD
Sulindac—Constipation—Prednisone—chronic obstructive pulmonary disease	5.66e-05	0.000736	CcSEcCtD
Sulindac—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.45e-05	0.00071	CcSEcCtD
Sulindac—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.41e-05	0.000704	CcSEcCtD
Sulindac—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.41e-05	0.000704	CcSEcCtD
Sulindac—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.25e-05	0.000684	CcSEcCtD
Sulindac—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.23e-05	0.000681	CcSEcCtD
Sulindac—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.87e-05	0.000634	CcSEcCtD
Sulindac—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.75e-05	0.000618	CcSEcCtD
Sulindac—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.68e-05	0.000609	CcSEcCtD
Sulindac—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.53e-05	0.000589	CcSEcCtD
Sulindac—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.37e-05	0.000569	CcSEcCtD
Sulindac—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.21e-05	0.000548	CcSEcCtD
Sulindac—Rash—Prednisone—chronic obstructive pulmonary disease	4.17e-05	0.000543	CcSEcCtD
Sulindac—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.17e-05	0.000542	CcSEcCtD
Sulindac—Headache—Prednisone—chronic obstructive pulmonary disease	4.14e-05	0.00054	CcSEcCtD
Sulindac—Nausea—Prednisone—chronic obstructive pulmonary disease	3.93e-05	0.000512	CcSEcCtD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.37e-05	0.000346	CbGpPWpGaD
Sulindac—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	2.37e-05	0.000345	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.37e-05	0.000344	CbGpPWpGaD
Sulindac—PPARD—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.35e-05	0.000343	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	2.35e-05	0.000342	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.35e-05	0.000342	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.34e-05	0.000341	CbGpPWpGaD
Sulindac—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	2.34e-05	0.00034	CbGpPWpGaD
Sulindac—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.33e-05	0.00034	CbGpPWpGaD
Sulindac—MAPK3—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	2.33e-05	0.000339	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	2.33e-05	0.000339	CbGpPWpGaD
Sulindac—PPARD—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.32e-05	0.000338	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.32e-05	0.000337	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL1B—chronic obstructive pulmonary disease	2.29e-05	0.000334	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—LEP—chronic obstructive pulmonary disease	2.29e-05	0.000333	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.27e-05	0.000331	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.26e-05	0.000329	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	2.26e-05	0.000328	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	2.24e-05	0.000327	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	2.23e-05	0.000325	CbGpPWpGaD
Sulindac—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	2.23e-05	0.000324	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—IL6—chronic obstructive pulmonary disease	2.23e-05	0.000324	CbGpPWpGaD
Sulindac—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	2.22e-05	0.000324	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.21e-05	0.000322	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	2.21e-05	0.000321	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	2.19e-05	0.000319	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.18e-05	0.000317	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.17e-05	0.000316	CbGpPWpGaD
Sulindac—PPARD—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.16e-05	0.000315	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.16e-05	0.000314	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.15e-05	0.000314	CbGpPWpGaD
Sulindac—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.14e-05	0.000312	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	2.12e-05	0.000308	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	2.09e-05	0.000304	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.09e-05	0.000304	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.09e-05	0.000304	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	2.08e-05	0.000303	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.08e-05	0.000302	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	2.08e-05	0.000302	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	2.07e-05	0.000301	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.07e-05	0.000301	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CRP—chronic obstructive pulmonary disease	2.06e-05	0.0003	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—IL6—chronic obstructive pulmonary disease	2.06e-05	0.0003	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.06e-05	0.0003	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	2.05e-05	0.000299	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.05e-05	0.000299	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	2.04e-05	0.000296	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—TP53—chronic obstructive pulmonary disease	2.04e-05	0.000296	CbGpPWpGaD
Sulindac—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.03e-05	0.000296	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.02e-05	0.000294	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.02e-05	0.000294	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—CTGF—chronic obstructive pulmonary disease	2.01e-05	0.000293	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.99e-05	0.00029	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.98e-05	0.000289	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—TLR4—chronic obstructive pulmonary disease	1.98e-05	0.000288	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	1.98e-05	0.000288	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.94e-05	0.000282	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—IL6—chronic obstructive pulmonary disease	1.94e-05	0.000282	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	1.94e-05	0.000282	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	1.94e-05	0.000282	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	1.93e-05	0.000281	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—MMP9—chronic obstructive pulmonary disease	1.93e-05	0.00028	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.92e-05	0.00028	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	1.92e-05	0.00028	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	1.9e-05	0.000277	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	1.9e-05	0.000276	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	1.89e-05	0.000275	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—HDAC2—chronic obstructive pulmonary disease	1.87e-05	0.000273	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TLR2—chronic obstructive pulmonary disease	1.86e-05	0.000271	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—IL6—chronic obstructive pulmonary disease	1.86e-05	0.000271	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.85e-05	0.00027	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.8e-05	0.000261	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.77e-05	0.000258	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.76e-05	0.000256	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.76e-05	0.000256	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.76e-05	0.000256	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—ALB—chronic obstructive pulmonary disease	1.76e-05	0.000256	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.76e-05	0.000255	CbGpPWpGaD
Sulindac—MAPK3—Immune System—KL—chronic obstructive pulmonary disease	1.75e-05	0.000255	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	1.74e-05	0.000254	CbGpPWpGaD
Sulindac—MAPK3—Disease—HDAC2—chronic obstructive pulmonary disease	1.74e-05	0.000253	CbGpPWpGaD
Sulindac—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	1.73e-05	0.000252	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—VEGFA—chronic obstructive pulmonary disease	1.73e-05	0.000252	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.72e-05	0.000251	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	1.72e-05	0.00025	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	1.72e-05	0.00025	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.71e-05	0.000249	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.69e-05	0.000246	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.68e-05	0.000244	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	1.68e-05	0.000244	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.67e-05	0.000244	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.67e-05	0.000243	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.66e-05	0.000242	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.66e-05	0.000241	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	1.64e-05	0.000239	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	1.63e-05	0.000238	CbGpPWpGaD
Sulindac—MAPK3—Disease—KL—chronic obstructive pulmonary disease	1.62e-05	0.000236	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	1.6e-05	0.000232	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.59e-05	0.000232	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.58e-05	0.00023	CbGpPWpGaD
Sulindac—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.57e-05	0.000229	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.57e-05	0.000228	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	1.56e-05	0.000227	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.56e-05	0.000227	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.56e-05	0.000227	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—EGFR—chronic obstructive pulmonary disease	1.56e-05	0.000226	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	1.54e-05	0.000224	CbGpPWpGaD
Sulindac—ALB—Metabolism—GC—chronic obstructive pulmonary disease	1.53e-05	0.000222	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.44e-05	0.00021	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.43e-05	0.000208	CbGpPWpGaD
Sulindac—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.42e-05	0.000207	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD8A—chronic obstructive pulmonary disease	1.41e-05	0.000206	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.41e-05	0.000205	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	1.41e-05	0.000205	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.41e-05	0.000205	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.4e-05	0.000204	CbGpPWpGaD
Sulindac—PPARD—Metabolism—ALB—chronic obstructive pulmonary disease	1.39e-05	0.000203	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.38e-05	0.000201	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.37e-05	0.0002	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.34e-05	0.000196	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	1.34e-05	0.000196	CbGpPWpGaD
Sulindac—PPARD—Metabolism—NOS3—chronic obstructive pulmonary disease	1.33e-05	0.000194	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—IL6—chronic obstructive pulmonary disease	1.32e-05	0.000192	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ERBB3—chronic obstructive pulmonary disease	1.31e-05	0.000191	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.31e-05	0.000191	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.3e-05	0.000189	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.29e-05	0.000187	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.28e-05	0.000187	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.23e-05	0.00018	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.22e-05	0.000177	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.22e-05	0.000177	CbGpPWpGaD
Sulindac—MAPK3—Disease—ERBB3—chronic obstructive pulmonary disease	1.21e-05	0.000177	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.21e-05	0.000176	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CRP—chronic obstructive pulmonary disease	1.2e-05	0.000175	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.2e-05	0.000174	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—IL6—chronic obstructive pulmonary disease	1.2e-05	0.000174	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.19e-05	0.000173	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.18e-05	0.000172	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.17e-05	0.000171	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TLR4—chronic obstructive pulmonary disease	1.15e-05	0.000168	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.13e-05	0.000165	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.13e-05	0.000165	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.13e-05	0.000165	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.13e-05	0.000164	CbGpPWpGaD
Sulindac—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.11e-05	0.000162	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.11e-05	0.000162	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.11e-05	0.000162	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.1e-05	0.00016	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.09e-05	0.000159	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.08e-05	0.000157	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.08e-05	0.000157	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.07e-05	0.000156	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.06e-05	0.000154	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.05e-05	0.000152	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.04e-05	0.000151	CbGpPWpGaD
Sulindac—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	1.04e-05	0.000151	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.03e-05	0.00015	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.02e-05	0.000148	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS2—chronic obstructive pulmonary disease	1.01e-05	0.000147	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.01e-05	0.000146	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.93e-06	0.000145	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.89e-06	0.000144	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—EGFR—chronic obstructive pulmonary disease	9.8e-06	0.000143	CbGpPWpGaD
Sulindac—PTGS2—Disease—KL—chronic obstructive pulmonary disease	9.62e-06	0.00014	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.51e-06	0.000138	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.35e-06	0.000136	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.3e-06	0.000135	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	9.17e-06	0.000134	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.15e-06	0.000133	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—chronic obstructive pulmonary disease	9.14e-06	0.000133	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.05e-06	0.000132	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.01e-06	0.000131	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.88e-06	0.000129	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—chronic obstructive pulmonary disease	8.63e-06	0.000126	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.57e-06	0.000125	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.55e-06	0.000124	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—IL6—chronic obstructive pulmonary disease	8.53e-06	0.000124	CbGpPWpGaD
Sulindac—MAPK3—Disease—SERPINE1—chronic obstructive pulmonary disease	8.52e-06	0.000124	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.49e-06	0.000124	CbGpPWpGaD
Sulindac—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	8.46e-06	0.000123	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.44e-06	0.000123	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.35e-06	0.000121	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.28e-06	0.00012	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.26e-06	0.00012	CbGpPWpGaD
Sulindac—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	8.25e-06	0.00012	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.18e-06	0.000119	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS3—chronic obstructive pulmonary disease	8.13e-06	0.000118	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	8.08e-06	0.000118	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.91e-06	0.000115	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.85e-06	0.000114	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.61e-06	0.000111	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.6e-06	0.000111	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IL6—chronic obstructive pulmonary disease	7.53e-06	0.00011	CbGpPWpGaD
Sulindac—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	7.53e-06	0.00011	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL1B—chronic obstructive pulmonary disease	7.49e-06	0.000109	CbGpPWpGaD
Sulindac—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	7.21e-06	0.000105	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.15e-06	0.000104	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.05e-06	0.000103	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.94e-06	0.000101	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.57e-06	9.56e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.35e-06	9.24e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.26e-06	9.11e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.25e-06	9.1e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.23e-06	9.06e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	6.01e-06	8.75e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.96e-06	8.68e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.84e-06	8.5e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.83e-06	8.49e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	5.82e-06	8.47e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.78e-06	8.42e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.77e-06	8.4e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—EGFR—chronic obstructive pulmonary disease	5.71e-06	8.31e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.7e-06	8.3e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.69e-06	8.29e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.38e-06	7.83e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—TGFB1—chronic obstructive pulmonary disease	5.38e-06	7.83e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	5.34e-06	7.78e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	5.33e-06	7.76e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.32e-06	7.74e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—EGFR—chronic obstructive pulmonary disease	5.27e-06	7.67e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.27e-06	7.66e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.1e-06	7.42e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	5.07e-06	7.37e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.05e-06	7.35e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.04e-06	7.33e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	4.84e-06	7.04e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.8e-06	6.99e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.57e-06	6.65e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	4.4e-06	6.4e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—chronic obstructive pulmonary disease	4.39e-06	6.39e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	4.23e-06	6.16e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.1e-06	5.97e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—chronic obstructive pulmonary disease	4.05e-06	5.9e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.05e-06	5.89e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.05e-06	5.89e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.99e-06	5.81e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.77e-06	5.48e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	3.76e-06	5.47e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.72e-06	5.41e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.69e-06	5.37e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.59e-06	5.23e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.52e-06	5.13e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	3.28e-06	4.77e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	3.2e-06	4.65e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	3.14e-06	4.56e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.1e-06	4.51e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.84e-06	4.13e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	2.41e-06	3.51e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.4e-06	3.49e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.29e-06	3.34e-05	CbGpPWpGaD
